Concepedia

Gina Buckley

GB

Statistics

Publications

4

Citations

174

H-Index

4

Active since

2013

Affiliations

Pfizer (United States)(Current)

Gina Buckley is an author at Pfizer (United States) specializing in pharmacology, psychopharmacology, and depression pharmacotherapy.

Publications per year

2013–2024

4

Publications

4

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression

Sheldon Preskorn, Cecelia P. Kane, Kasia Lobello et al. · The Journal of Clinical Psychiatry · 2013 · 110 citations

, , +17

Abrupt Discontinuation Compared With a 1-Week Taper Regimen in Depressed Outpatients Treated for 24 Weeks With Desvenlafaxine 50 mg/d

Arif Khan, Jeff Musgnung, Tanya Ramey et al. · Journal of Clinical Psychopharmacology · 2014 · 31 citations

, , +17

Evaluation of an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose‐ranging, phase 2, randomized, placebo‐controlled study

Neeta B. Amin, Robert Frederich, Nikolaos Tsamandouras et al. · Diabetes Obesity and Metabolism · 2024 · 22 citations · Full text

, , +17

Incidence and Timing of Taper/Posttherapy–Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder

Philip T. Ninan, Jeff Musgnung, Michael Messig et al. · The Primary Care Companion For CNS Disorders · 2015 · 11 citations

, , +17

1–4 of 4